ACCOUNTS - Final Accounts preparation

ACCOUNTS - Final Accounts preparation


06697052 PK PHARMACARE LTD 2015-10-01 2016-09-30 false true 2016-09-30 06697052 2015-10-01 2016-09-30 06697052 2016-09-30 06697052 2015-09-30 06697052 c:FixturesFittingsToolsEquipment 2015-10-01 2016-09-30 06697052 d:OrdinaryShareClass1 2016-09-30 06697052 d:OrdinaryShareClass1 2015-09-30 06697052 d:OrdinaryShareClass1 2015-10-01 2016-09-30 06697052 d:Director1 2015-10-01 2016-09-30 06697052 d:Director2 2015-10-01 2016-09-30 06697052 c:NetGoodwill 2015-10-01 2016-09-30 xbrli:shares iso4217:GBP
Registered number: 06697052














PK PHARMACARE LTD

ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 SEPTEMBER 2016













SILVER LEVENE LLP
CHARTERED CERTIFIED ACCOUNTANTS
37 WARREN STREET 
LONDON W1T 6AD










 
PK PHARMACARE LTD
REGISTERED NUMBER: 06697052

ABBREVIATED BALANCE SHEET
AS AT 30 SEPTEMBER 2016

2016
2015
Note
£
£
£
£
 
FIXED ASSETS





 
Intangible assets
 
2
362,691

402,990
 
Tangible assets
 
3
3,028
4,038







365,719

407,028
 
CURRENT ASSETS





 
Stocks
59,625
52,923

 
Debtors
109,388
85,371

 
Cash at bank and in hand

382,810
261,577







 
551,823
399,871
 
CREDITORS: amounts falling due within one year
(377,294)
(308,662)
 
NET CURRENT ASSETS


174,529

91,209
 
TOTAL ASSETS LESS CURRENT LIABILITIES
540,248
498,237
 
CREDITORS: amounts falling due after more than one year
(157,992)

(206,376)

NET ASSETS




 382,256


 291,861
  
CAPITAL AND RESERVES

 
Called up share capital
4
100
100
 
Profit and loss account
382,156
291,761
 
SHAREHOLDERS' FUNDS
 

 382,256

 291,861


The directors consider that the company is entitled to exemption from the requirement to have an audit under the provisions of section 477 of the Companies Act 2006 ("the Act") and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Act. 

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and for preparing financial statements which give a true and fair view of the state of affairs of the company as at 30 September 2016 and of its profit for the year in accordance with the requirements of sections 394 and 395 of the Act and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.


Page 1

 
PK PHARMACARE LTD
 
    
ABBREVIATED BALANCE SHEET (continued)
AS AT 30 SEPTEMBER 2016

The abbreviated accounts, which have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006, were approved and authorised for issue by the board and were signed on its behalf on 24 February 2017.





Mr K Shah
Mrs P Shah
Director
Director

The notes on pages 3 to 4 form part of these financial statements.

Page 2

 
PK PHARMACARE LTD
 
 
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 SEPTEMBER 2016

1.ACCOUNTING POLICIES

1.1
Basis of preparation of financial statements

The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

1.2
Turnover

Turnover comprises revenue recognised by the company in respect of goods and services supplied during the year, exclusive of Value Added Tax and trade discounts.

1.3
Intangible fixed assets and amortisation

Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the identifiable assets and liabilities. It is amortised to the Profit and Loss Account over its estimated economic life.

Amortisation is provided at the following rates:
 
Goodwill
-
15 years straight line

1.4
Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less depreciation.  Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & fittings
-
25% reducing balance

1.5
Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

Page 3

 
PK PHARMACARE LTD
 
 
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 30 SEPTEMBER 2016

2.INTANGIBLE FIXED ASSETS



£


Cost



At 1 October 2015 and 30 September 2016

604,485

Amortisation


At 1 October 2015
201,495

Charge for the year
40,299


At 30 September 2016

241,794




Net book value


At 30 September 2016
 362,691


At 30 September 2015

 402,990


3.TANGIBLE FIXED ASSETS



£


Cost 



At 1 October 2015 and 30 September 2016

9,402



Depreciation


At 1 October 2015
5,364

Charge for the year
1,010


At 30 September 2016

6,374




Net book value


At 30 September 2016
 3,028


At 30 September 2015

 4,038


4.SHARE CAPITAL
        2016
        2015
        £

        £

Allotted, called up and fully paid



100 Ordinary shares of £1 each
 100
 100


5.CONTROLLING PARTY

The company was under the control of the directors Mr K Shah (50% share) and Mrs P Shah (50% share), by virtue of the fact that they own 100% of the issued share capital.

Page 4